Cyclerion Therapeutics Inc. (NASDAQ: CYCN)
$3.29
+0.3700 ( +12.67% ) 1.8K
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Market Data
Open
$3.29
Previous close
$2.92
Volume
1.8K
Market cap
$7.37M
Day range
$2.79 - $3.18
52 week range
$1.75 - $5.25
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3/a | Insider transactions | 1 | Dec 07, 2023 |
8-k | 8K-related | 13 | Dec 04, 2023 |
4 | Insider transactions | 1 | Dec 04, 2023 |
4 | Insider transactions | 1 | Dec 04, 2023 |
4 | Insider transactions | 1 | Dec 04, 2023 |
4 | Insider transactions | 1 | Dec 04, 2023 |
3 | Insider transactions | 1 | Dec 04, 2023 |
8-k | 8K-related | 14 | Dec 01, 2023 |
8-k | 8K-related | 12 | Nov 24, 2023 |
10-q | Quarterly Reports | 70 | Nov 13, 2023 |